Somapacitan - Growth failure - adults
You are here : Home > Formulary Search > Somapacitan - Growth failure - adults
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Non Formulary
Formulations :
No records returned.
Formulary Status :
Associated Icons :
NFD1
SPC
Restrictions / Comments :
Important
This drug should not be initiated in adult patients, but treatment initiated in <17yrs can be continued until final growth height attained, see growth failure - children page.
Documents :
NICE Technology Appraisal
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Somapacitan
Indication :
Growth failure - adults
Group Name :
Keywords :
Brand Names Include :
Sogroya
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
2
Committee Recommendations (1)
The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) agrees a NON-FORMULARY status for those patients initiated on somapacitan treatment as adults (18 years and over).
Other Indications
Below are listed other indications that Somapacitan is used to treat.